Clinical Trial: A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth

U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215676) titled 'A Trial of a Multi-Component Nutritional Supplement in Hydrogen-Dominant Small Intestinal Bacterial Overgrowth' on Sept. 16.

Brief Summary: The goal of this trial is to evaluate the safety and tolerability of an 8-week, multi-component nutritional supplement (AV1PD1A) in adults with hydrogen-dominant small intestinal bacterial overgrowth (SIBO).

The main questions the study aims to answer are:

1. Is the product safe and well-tolerated over 8 weeks, as measured by bloodwork, vital signs, and adverse effects?

2. How many participants adhere to the intervention without a dose modification, hold, or discontinuation?

Exploratory ques...